Search Results 911-920 of 8099 for TNF

1. Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 - Mayo Clinic

   About this study. This is a study to evaluate the hypothesis that FDA cleared thrombectomy devices plus medical management leads to superior clinical ...

2. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   About this study. RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate, goserelin acetate, ...

3. A Study of Identification of Barriers to Care in Patients with Progressive Multiple Sclerosis - Mayo Clinic

   The purpose of this study is to gain an understanding of the progressive multiple sclerosis (MS) experience and the meaning patients bring to the experience. By ...

4. Advancing Prevention of Pulmonary Fibrosis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   This study will also evaluate other anti-tumor effects, tumor markers and pharmacokinetics (PK) of zolbetuximab, Nab-P and GEM. Participation eligibility.

6. Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy - Mayo Clinic

   Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy.

7. ALN-TTR02-012 - Mayo Clinic

   To evaluate the effectiveness of Patisiran on ambulatory status in patients with hATTR amyloidosis with polyneuropathy who have a V122I or T60A mutation.

8. Post-transplant NASH Protocol to Assess the Development of Metabolic Co-morbidities and Disease Recurrence in Patients Transplanted for NASH Cirrhosis - Mayo Clinic

   The purpose of this study is to identify risk factors and potential predictors for NAFLD and NASH recurrence after liver transplantation. Participation ...

9. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

   About this study. The purpose of this randomized, open-label, multi-center, global, Phase III study is to determine the efficacy and safety of durvalumab + ...

10. Multiband EPI Pulse Sequence for Use in Language fMRI - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...